Yangzhou Song
松阳洲
Yangzhou Song (松阳洲) is the founder and chief scientist of Pusillabio (普世利华), a molecular diagnostics company and a Qiming Venture Partners portfolio company, and a professor in the School of Life Sciences at Sun Yat-sen University . His team built a palm-sized, near-patient molecular testing platform aimed at breaking the limits of conventional diagnostics — per Qiming's profile, using "a single swab" to bring testing for tuberculosis, the "top killer," to grassroots healthcare systems . His profile peaked in early 2026: he was named to TIME's 2026 TIME100 Health list of the world's most influential people in health, with TIME's citation focusing on his team's contributions to TB detection , and VBData later included him in its 2026 healthcare innovation "50 influential scientists" .
AI-generated — may contain errors, please verify.
Coverage
Qiming Venture Partners and Nearly 40 Portfolio Companies Named to VBData 2026 Future Healthcare 100
China's most authoritative and influential innovation benchmark for the healthcare industry
Qiming Stars | Pusillabio's Song Yangzhou: Using a Single Swab to Make the 'Top Killer' Nowhere to Hide
The value of a technology isn't determined on the day it's launched, but on every day thereafter — when it's repeatedly tested, refined, and put to use again and again.
Qiming Venture Partners | Pusilihua Founder Professor Song Yangzhou Named to TIME100 Health 2026 List of World's Most Influential People in Health
In the official selection rationale released by TIME, the focus was on the extraordinary contributions that Professor Songyang Zhou and his team at Pusillabio have made in the field of tuberculosis detection.
Qiming Weekly | Qiming Venture Partners Portfolio Companies: Funding and Updates Vol. 18, 2025
Staying with you through milestone moments for Qiming Venture Partners' portfolio companies
